EGOI-PCOS
  • The Group
    • Experts on Inositol
    • Experts on PMOS (PCOS)
    • Mission
    • Regulations and Statute
  • Clinical Centers
  • Publications
  • Activities
    • Fellowship
  • Affiliations
    • Support
  • Register
  • Login
Select Page

Insights from the EGOI-PCOS patient survey: Diagnosis, treatment, and quality of life according to Italian PCOS patients

Jun 13, 2025

Authors: Carriero VC, Forte G, Dinicola S, Oliva MM, Al Mudarris G., Unfer V.

Endocrine Metabolic Syndrome and Metabolic Syndrome: Distinct but Interrelated Pathologies

Apr 23, 2025

Authors: Myers SH, Soulage CO, Unfer V.

D-chiro-inositol effectively counteracts endometriosis in a mouse model

Apr 23, 2025

Authors: Placidi M, Casoli G, Vergara T, Bianchi A, Cocciolone D, Zaccardi S, Macchiarelli G, Palmerini MG, Tatone C, Bevilacqua A, Di Emidio G.

The Therapeutic Potential of Myo-Inositol in Managing Patients with Respiratory Diseases

Apr 2, 2025

Authors: Quecchia C, Vianello A.

Unexpected effects of treating insulin-resistant obese women with high-dose D-chiro-inositol: opening Pandora’s box

Apr 2, 2025

Authors: Sabrina Basciani, Maurizio Nordio, Maria Letizia Spizzichini and Lucio Gnessi

A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.”

Apr 2, 2025

Authors: Aragona C, Russo M, Myers SH, Espinola MSB, Bilotta G, Unfer V.
« Older Entries
Next Entries »


Viale di Villa Massimo 37, 00161, Rome (Italy)
Email: office@inositolgroup.com
P.IVA / VAT ID: 96501700585

Subscribe to our Newsletter

Terms of use

Privacy and Cookie Policy
Registration Privacy Policy

All Rights Reserved ©2020 The Experts Group on Inositols in Basic and Clinical Research (EGOI)